About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack

by Medindia Content Team on July 31, 2006 at 6:37 PM
Font : A-A+

Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack

The Hyderabad-based Aurobindo Pharma Ltd today said it has received the tentative new drug approval for a fixed drug combination product used for anti-HIV treatment.

The fixed drug compbination product contains Lamivudine 150mg+2idovudine300mg tablets co-packaged with Abacavir 300mg Tablets, the company informed the Bombay Stock Exchange.

Advertisement

This combination pack enhances convenience, is cost-effective and reduces the threat of resistance due to missed doses.

This is the first new drug generic approval in the world for a three-drug combination pack. These three drugs command over six hundred million-dollar market worldwide and the usage of the drugs is growing.

With this approval, the antiretroviral product portfolio of Aurobindo increased to 18 including three NDA approvals.

The shares of the company were trading at Rs 640.05, up 2.52 per cent at the BSE.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Daily Calorie Requirements A-Z Drug Brands in India Blood Donation - Recipients Hearing Loss Calculator Drug - Food Interactions Indian Medical Journals Accident and Trauma Care Find a Hospital Vent Forte (Theophylline) Drug Side Effects Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use